| 18852005
|
Deceptive imprinting and immune refocusing in vaccine design. |
Vaccine |
2008 |
Tobin GJ;Trujillo JD;Bushnell RV;Lin G;Chaudhuri AR;Long J;Barrera J;Pena L;Grubman MJ;Nara PL |
View
More |
| 27853256
|
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses. |
Sci Rep |
2016 |
Tomusange K;Wijesundara D;Gummow J;Wesselingh S;Suhrbier A;Gowans EJ;Grubor-Bauk B |
View
More |
| 33911008
|
Genome-Wide B Cell, CD4(+), and CD8(+) T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines. |
J Immunol |
2021 |
Prakash S;Srivastava R;Coulon PG;Dhanushkodi NR;Chentoufi AA;Tifrea DF;Edwards RA;Figueroa CJ;Schubl SD;Hsieh L;Buchmeier MJ;Bouziane M;Nesburn AB;Kuppermann BD;BenMohamed L |
View
More |
| 35343783
|
Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation. |
J Virol |
2022 |
Nguyen HT;Qualizza A;Anang S;Zhao M;Zou S;Zhou R;Wang Q;Zhang S;Deshpande A;Ding H;Chiu TJ;Smith AB 3rd;Kappes JC;Sodroski JG |
View
More |
| 9420270
|
Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1. |
J Virol |
1998 |
Smith AD;Geisler SC;Chen AA;Resnick DA;Roy BM;Lewi PJ;Arnold E;Arnold GF |
View
More |
